- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$2.04 BnMarket Estimate, 2026
$2.18 BnMarket Forecast, 2034
$3.59 BnCAGR, 2026–2034
6.45%Executive Summary: North America Vascular Access Devices Market
- Market Scope: Comprehensive regional analysis of the North America vascular access devices sector, detailing device categories, clinical applications, end-user settings, and country-level profiles spanning 2026 to 2034.
- Market Valuation: Valued at USD 2.04 billion in 2025, reaching USD 2.18 billion in 2026, and projected to expand to USD 3.59 billion by 2034, growing at a robust CAGR of 6.45% from 2026 to 2034.
- Primary Growth Drivers: Rising prevalence of chronic and lifestyle disorders (such as cancer, diabetes, and end-stage renal disease), expansion of chemotherapy and long-term intravenous therapies, and increasing governmental investments in healthcare infrastructure.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Type | Central Vascular Access Devices (held dominant market share, driven by extensive utilization in critical care, oncology, and long-term infusions) | Peripheral Vascular Access Devices (projected at the highest growth rate, fueled by extended-dwell designs and ultrasound-guided placements) |
| By Application | Drug Administration (captured the major market share, backed by widespread requirements for chemotherapy and antimicrobial treatments) | Fluid & Nutrition Administration (growing rapidly due to rising demands for extended intravenous nutritional support in hospital settings) |
| By End Users | Hospitals (remained the largest end-user segment, supported by high volumes of inpatient interventions, renal dialysis, and acute care) | Ambulatory Care Centers (anticipated to register high-speed growth, driven by shifts toward outpatient infusion services and cost-effective care) |
| By Country | U.S. (market leader with the highest regional share, backed by mature healthcare infrastructure, high chronic disease prevalence, and advanced technology adoption) | Canada (key expanding market driven by rising geriatric demographics, chronic kidney disease management, and regional medical device investments) |
Major Market Players & Industry Landscape
Market Structure: Highly competitive and mature environment characterized by intense pricing pressures, average selling price (ASP) adjustments, and major global companies expanding product portfolios through advanced safety innovations.
Key Companies: Becton Dickinson and Company, C.R. Bard Inc., Teleflex Incorporated, B. Braun Melsungen AG, and Smiths Medical, Inc.
Download Free Sample Report
North America Vascular Access Devices Market Size
The North America Vascular Access Devices Market was valued at USD 2.04 billion in 2025, is expected to have 6.45% CAGR from 2026 to 2034 and be worth USD 3.59 billion by 2034 from USD 2.18 billion in 2026.
The rising frequency of lifestyle diseases, growth in chemotherapy operations, and the increasing usage of vascular access devices in pediatric patients are key market drivers in the North American region. Blood transfusions are becoming more common, especially in this region. Patients demand central venous access during long-term intravenous therapy such as chemotherapy, and antimicrobial treatment is driving market expansion. Increase in government investment in healthcare infrastructure is likely to assist market development.
In addition, an increase in the number of occurrences of lifestyle-related disorders increased knowledge of preventive healthcare, and clinical studies for vascular access devices in the region are boosting the market growth. Cancer, renal failure, and heart disease are only a few of the leading chronic diseases. Several lifestyle disorders are associated with chronic and non-communicable disease conditions, such as hypertension, diabetes, obesity, and depression, that require acute treatment while in the hospital.
In addition, intravenous antibiotic therapy, extended intravenous nutritional support, and blood sample collection are becoming more familiar with vascular access procedures. As a result, various medical device businesses are likely to invest and launch new products, functioning as one of the market's primary drivers.
The cost of maintaining and implanting vascular access devices is relatively high, which may restrict the North American vascular access devices market's growth.
Geographically, the North American market was predicted to hold the highest share of the industry. The high frequency of cardiovascular disorders in the United States, an increase in cancer cases, and an increase in research contribute to this industry's significant share. Technological advancements in medical device development, together with an increase in the number of procedures performed that need modern medical equipment, are having a more significant impact on market growth.
Leading global companies are growing their presence in developing countries such as the US and Canada to take advantage of these countries' growth prospects. The frequency of end-stage renal disease (ESRD) is increasing at an alarming rate, resulting in chronic kidney disease. In 2019, over 35 million persons were diagnosed with chronic renal disease in the United States. The region's expansion is fueled by its established healthcare infrastructure, expanding cancer-related causes, and increased investments in research and clinical trials.
The United States vascular access devices market is mature and will decrease somewhat over the forecast period. Intense pricing pressures, which will result in dropping ASPs in most product sectors, will counteract rising unit sales, driven by an expanding patient pool in the United States.
KEY MARKET PLAYERS AND COMPETITIVE LANDSCAPE
Companies playing a dominant role in the North America Vascular Access Devices Market profiled in this report are Becton Dickinson and Company, C.R.Bard Inc, Smiths Medical, Inc., Teleflex Incorporated, B Braun Melsungen Ag, AngioDynamics, Terumo Corporation, Nipro Medical Corporation, Edwards Lifesciences Corporation, Ameco Medical, Romsons Scientific & Surgical Pvt. Ltd, and Prodimed.,
MARKET SEGMENTATION
This research report on the North America Vascular Access Devices Market has been segmented and sub-segmented into the following categories
By Type Insights
-
Peripheral
- Central
- Accessories
By Application Insights
-
Drug Administration
-
Fluid & Nutrition Administration
- Blood Transfusion
- Diagnostics Testing
By End Users Insights
-
Hospitals
-
Clinics
- Ambulatory Care Centers
- Other End Users
By Country
- U.S
- Canada
- Rest of North America